Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab clinical trial (NCT06141265). Contact the study team or your healthcare provider for specific answers.

Question 2

How does niraparib compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab clinical trial (NCT06141265). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of niraparib that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab clinical trial (NCT06141265). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab clinical trial (NCT06141265). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the trial in terms of tests and procedures?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab clinical trial (NCT06141265). Contact the study team or your healthcare provider for specific answers.

Question 6

How will participating in this trial impact my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab clinical trial (NCT06141265). Contact the study team or your healthcare provider for specific answers.

What this study is about